[In vivo studies on the metabolism of pyrimidine nucleosides (author's transl)].
3H-labelled metabolites were determined in the perchloric acid-soluble fraction of blood plasma and liver of adult male Wistar rats, following the application of [5 - 3H]uridine. Ten minutes after the injection of uridine, only 20% of the total 3H activity of the plasma could be attributed to [3H]uridine. The remaining radioactivity was found chiefly in [3H]uracil (40%) and 3H2O (20%). In the liver, at 10 min, [3H]-uridine and [3H]uracil together accounted for less than 0.5% of the total radioactivity; about 70% of the radioactivity was due to [3H]beta-alanine, and 15% to 3H2O. 45 min after the injection, 70% of the radioactivity in the plasma was due to 3H2O, whereas uridine and uracil represented about 4% and 6%, respectively. At this time, about 55% of the radioactivity in the liver was due to [3H]beta-alanine, about 40% to 3H2O, and about 5% to unidentified metabolites; [3H]uridine and [3H]uracil were not observed. A comparison of the rate of catabolism of [5-3H]-uridine, [5-3H]cytidine and [6-3H]thymidine showed that cytidine is degraded in the organism 25 times more slowly than uridine or thymidine. The biological half lives for the total degradation of the [3H]nucleosides to 3H2O, based on the values in the plasma, were: uridine 1.1 h; thymidine 1.3 h; cytidine 25 h. Furthermore, the turnover time of exogenous uridine in the plasma was found to be 9 min, which gives a half life of 6 min for the metabolism of exogenous uridine to uracil.
D000409:Alanine / Q000378:metabolism; D000818:Animals; D003562:Cytidine / Q000378:metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D011741:Pyrimidine Nucleosides / Q000378:metabolism*; D051381:Rats; D013936:Thymidine / Q000378:metabolism; D013997:Time Factors; D014498:Uracil / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D011741:Pyrimidine Nucleosides; D014498:Uracil; D003562:Cytidine; D000409:Alanine; D013936:Thymidine; D014529:Uridine
In-vivo-Untersuchungen zur Metabolisierung der Pyrimidinnucleoside